CARBON Newsletter (9 August) - Your Latest News...
Carbon
Aug. 9, 2022
Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.
Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.
Always stay updated with the free CMN Newsletter.
CRISPR QC
Main focus: CRISPR gene-editing quality control
Company stage: Pre-clinical
Diseases (gene editing): Sickle-cell disease, genetic blindness, amyloidosis (ATTR), type I diabetes
Genome editing tool: CRISPR/Cas9
Funding stage: Private
Location: San Diego, California, USA
Website: https://www.crisprqc.com/?hsLang=en
CRISPR QC provides unique insights on CRISPR mechanics (i.e. cleavage activity, gRNA binding, complex stability), allowing therapeutic companies to optimize gene-editing outcomes.
